KGKatarzyna Gadżała

Katarzyna Gadżała

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katarzyna Gadżała has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Worldwide Problem of Obesity - Comparison of the Effectiveness of Pharmacological Treatment with Semaglutide and Tirzepatide in Reducing Body Weight

    by Karolina Garbino, Katarzyna Brudniak, Magdalena Czyczerska, Antoni Szuścik, Katarzyna Gadżała, Sabina Przygodzka, Maciej Mach, Maciej Rutkiewicz

    Introduction Obesity is a disease that has been affecting an increasing number of people in the last decade. In addition to surgical and dietary treatment, pharmacological treatment plays an important role in its treatment. Obesity is a risk factor for many diseases, including cardiovascular disease and diabetes, and increases the risk of mortality, which is why appropriate treatment is so important. Comparison of pharmacological treatment methods using two preparations from the group of GLP-1 analogues, such as semaglutide and tirzepatide, available for prescription use in European Union countries, may help select the most effective therapy tailored to the patient. Aim of the body The aim of the study was to summarise and compare the two preparations available for use by patients in terms of their mode of action and their impact on body weight reduction. Methods and Materials The following keywords were used to review the literature available in the PubMed database: "obesity", "semaglutide", "tirzepatide", "weight loss after semaglutide treatment", "weight loss after tirzepatide treatment" and "treatment of obesity". We also used literature available in other scientific journals, literature available on Google Scholar and data collected and stored by WHO.


  • Open Access

    Postpartum Depression: A Closer Look at Treatment with Zuranolone

    by Katarzyna Brudniak, Karolina Garbino, Magdalena Czyczerska, Antoni Szuścik, Katarzyna Gadżała, Sabina Przygodzka, Maciej Mach, Maciej Rutkiewicz

    Postpartum depression (PPD) is a severe mood disorder that affects approximately 1 in 7 women and 1 in 10 men, often occurring in the first year after childbirth. Its etiology is multifactorial, including hormonal changes, genetic predisposition, and environmental stressors, though its true prevalence is likely underestimated due to stigma and underreporting. Untreated PPD can have long-term consequences for maternal-child relationships, child development, and maternal health, including increased suicide risk. The condition remains underdiagnosed and undertreated due to stigma and systemic barriers to care. Zuranolone, an oral neuroactive steroid and positive allosteric modulator of GABA-A receptors, has recently garnered attention as a novel therapeutic option with the potential to target these underlying pathophysiological mechanisms. Aim of the study: The aim of this study is to provide a comprehensive review of the therapeutic efficacy, safety, and pharmacological characteristics of Zuranolone in the treatment of postpartum depression (PPD), with focusing particularly on its mechanism of action, pharmacokinetics and clinical trial outcomes. Materials and methods: A systematic literature review was conducted using PubMed and other medical databases. Keywords included "postpartum depression," "zuranolone," "GABA-A modulators,". Data from clinical trials, reviews, and pharmacological studies were analyzed. Conclusions: Zuranolone has provided significant efficacy with a very rapid onset of action in the reduction of symptoms in postpartum depression and long-term improvements observed over several weeks. Its mechanism of action, targeting GABAergic dysregulation, offers a novel therapeutic pathway for addressing postpartum psychiatric disorders. Future longitudinal studies are required to explore its long-term impact on maternal mental health.

  • Open Access

    Do Painted Nails Increase Bacterial Transmission in Healthcare Environments? A Literature Review

    by Katarzyna Brudniak, Karolina Garbino, Magdalena Czyczerska, Antoni Szuścik, Katarzyna Gadżała, Sabina Przygodzka, Maciej Mach, Maciej Rutkiewicz

    Introduction: Healthcare-associated infections (HAIs) continue to be a significant global concern, leading to increased patient morbidity, prolonged hospitalizations, and elevated healthcare costs. Hand hygiene remains the most critical part of infection prevention, however the use of nail polish and artificial nails has raised questions regarding their possible contribution to bacterial transmission. Aim of study :The aim of this study is to collect and examine whether painted nails significantly influence bacterial spread in healthcare settings, focusing on nail surface properties, hand hygiene practices and existing guidelines. Materials and Methods: A literature review was conducted with PubMed and other medical databases using appropriate keywords. Data from clinical trials and reviews were analyzed. Conclusions: Intact nail polish does not pose a significant risk for bacterial transmission in healthcare environments when proper hand hygiene protocols are followed. Emphasis should remain on keeping short, clean nails and adhering to strict hand hygiene practices to reduce healthcare-associated infections (HAIs). Keywords: nail polish, hand hygiene, healthcare-associated infections, articial fingernails in a hospital environment

  • Open Access

    Contamination of dietary supplements: the impact of the undeclared compounds on health, consequences of daily usage and prevention strategies

    by Sabina Przygodzka, Maciej Rutkiewicz, Katarzyna Gadżała, Karolina Garbino, Katarzyna Brudniak, Antoni Szuścik Szuścik, Magdalena Czyczerska

    Throughout recent years, dietary supplement usage significantly increased. The reason behind it is a desire to enhance physical performance due to the healthy-body trend. As the primarily unregulated market grows, so does the possibility of consumer exploitation. By releasing products intentionally or unintentionally contaminated by undeclared active compounds, producers endanger the health of many people worldwide. Components found in ergonutritional products have a broad spectrum of properties but also many adverse effects, which may occur in long-term use, including cardiovascular, neurological complications, and hormonal imbalance, among others. It is pivotal for users to be aware of the possible risks of DS consumption and crucial for governments to tighten regulations regarding manufacturing, testing, and labeling food supplements to ensure the safety of consumers.


  • Open Access

    Familial Hypercholesterolemia: Genetics, Symptoms, Diagnosis and Treatment - A Literature Overview

    by Maciej Rutkiewicz, Sabina Przygodzka, Katarzyna Gadżała, Karolina Garbino, Katarzyna Brudniak, Antoni Szuścik, Magdalena Czyczerska

    Familial hypercholesterolemia is a genetic disorder of lipid management, especially LDL-C. It's inherited autosomal dominant in most cases. The illness is characterized by high, low-density lipoprotein cholesterol (LDL-C) levels. According to many researchers, the frequency of prevalence is estimated at 1:200 in the global population. Many studies showed that illness is underdiagnosed and therefore undertreated. There are three known genes coding three different proteins, and changes are in charge of wrong lipid management. These are: LDL-Receptor (LDLR), Apolipoprotein B (ApoB), and Proprotein convertase subtilisin/kexin 9 (PCSK9). People who are affected by mutation have around thirteen times higher risk of coronary artery disease (CAD) and, in order to that, premature death. Identifying sickness includes a physical examination, when we can observe xanthomas, corneal arcus, or xanthomata, and scales that focus on the patient's as well as his family's past. A definite diagnosis can be approved by genetic testing, which shows a causable mutation. The main goal in treatment therapy of familial hypercholesterolemia is to reduce the concentration of LDL-C in serum. First of all, patients should know what to do to reduce LDL-C levels. Education is critical for understanding the problem and creating a successful course. Moreover, it is necessary to quit smoking, increase physical activity, and reduce cholesterol, elevating products from diet such as saturated fats and alcohol. Weight reduction is recommended. In addition, pharmacological treatment must be performed. All individuals have statins implemented. In most cases, one drug isn't enough, so therapy containing ezetimib is common. Novel treatments, including monoclonal antibodies (mAb), antisense oligonucleotides (ASO), and PCSK9- inhibitors nowadays, are used with greater frequency and better results, providing higher efficiency in achieving targets.


  • Open Access

    Mental Disorders in Children and Adolescents in Crisis Situations: The Impact of the COVID-19 Pandemic and Armed Conflicts - Types of Disorders, Effects, and Intervention Strategies

    by Katarzyna Gadżała, Sabina Przygodzka, Maciej Rutkiewicz, Karolina Garbino, Katarzyna Brudniak, Antoni Szuścik, Magdalena Czyczerska

    Introduction. The deterioration of mental health in children and adolescents is a serious medical problem, and the number of mental disorders has been increasing in recent years. In every part of the world, children and adolescents suffer from mental health problems, and their needs are not adequately taken care of. In addition, the outbreak of the COVID-19 pandemic and armed conflicts have had a significant impact on the emergence of disorders in children and adolescents. Loneliness, fear, anxiety and lack of emotional support and access to appropriate medical and psychological care are the basis of these problems. Support for young patients, psychological and pharmacological interventions and raising awareness about the importance of mental health are the basis for improving the mental health of adolescents. Aim of study. The aim of this study is to investigate the increasing prevalence of mental disorders among children and adolescents and to examine their correlation with the occurrence of pandemics, wars and traumas. Materials and methods. A non-systematic review of the scientific literature was conducted using specific keywords such as “children’s mental health”, “youth mental health”, “COVID-19 pandemic”, “war in Ukraine”, “armed conflicts”, “mental disorders”, “depression” and “anxiety”. The review was conducted in the Pub Med database, analyzing a total of 39 sources published by the end of 2024. Conclusions. Both the COVID-19 pandemic and armed conflicts have a negative impact on the mental health of children and adolescents worldwide. The occurrence of previous mental health problems significantly increases the risk of anxiety disorders, PTSD, depression. The basic strategy for preventing the occurrence and reducing the severity of these disorders are preventive programs, psychoeducation, psychotherapy, if necessary combined with pharmacotherapy.

  • Open Access

    Ozempic (semaglutide) - review of pharmacological properties, mechanism of action and clinical applications

    by Anna Maria Koman, Sabina Przygodzka, Katarzyna Gadżała, Izabela Janik, Marzena Pliszka, Karolina Alicja Palacz, Klaudia Brygida Kułak, Izabela Sztybór, Martyna Kuśmierska, Katarzyna Chamera-Cyrek

    Introduction: Ozempic is a new generation antihyperglycemic drug used to treat type 2 diabetes in adults whose underlying disease is not sufficiently controlled with physical activity and diet, as well as for long-term weight control in people with excess body weight and comorbidities. The aim of this study is to explore and integrate the latest literature on the analysis of the pharmacology, mechanism of action and clinical applications of Ozempic. Material and Methods of Research: A literature review focused on keywords related to the topic was performed using databases such as PubMed and Google Scholar. Results: Ozempic effectively lowers blood glucose levels and supports weight loss in patients with type 2 diabetes and obesity. Clinical trials have demonstrated its superiority over other antidiabetic medications, with significant reductions in HbA1c and body weight. Patients receiving Ozempic experienced improved glycemic control and cardiovascular outcomes, with manageable side effects. Ongoing research suggests additional benefits in cardiovascular prevention and obesity management. Conclusion: Ozempic (semaglutide) is a potent GLP-1 receptor agonist that effectively improves glycemic control and aids in weight reduction for patients with type 2 diabetes and obesity. Its practical administration, patient education, and regular monitoring are essential for optimal outcomes. Ongoing research and technological advancements, including the development of oral forms, promise to expand its applications and improve patient adherence, making Ozempic a versatile and valuable therapeutic option.


  • Open Access

    SGLT-2 inhibitors in heart failure: a literature review on mechanisms, efficacy and safety

    by Klaudia Kułak, Katarzyna Chamera-Cyrek, Izabela Janik, Martyna Kuśmierska, Anna Koman, Marzena Pliszka, Katarzyna Gadżała, Karolina Palacz, Izabela Sztybór, Sabina Przygodzka

    Introduction: Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors), known as flozins, are a recent class of medications gaining recognition for their effectiveness in diabetes, cardiovascular health, and heart failure management. The objective of this study is to examine and integrate recent literature concerning the mechanisms, effectiveness, and safety of SGLT2 inhibitors in managing heart failure. Material and Methods of Research: A literature review focused on keywords related to the topic was performed using databases such as PubMed and Google Scholar. Results: SGLT-2 inhibitors, initially developed for type 2 diabetes, significantly benefit heart failure (HF) with reduced, mildly reduced, and preserved ejection fractions by improving various cardiac outcomes. These drugs lower glucose levels and promote osmotic diuresis, natriuresis, and favorable metabolic effects, reducing cardiac preload and afterload. Consequently, SGLT-2 inhibitors are now pivotal in HF treatment, enhancing cardiac efficiency and reducing HF-related hospitalizations and mortality. Conclusion: SGLT-2 inhibitors substantially decrease cardiovascular risk and hospitalizations for heart failure in patients with or without type 2 diabetes, making them crucial in HF management. Consequently, SGLT-2 inhibitors should be considered first-line therapy for heart failure, regardless of concurrent medications, due to their efficacy and comprehensive benefits in managing this condition.


  • Open Access

    The Increasing Occurrence of Infectious Diseases in Childhood: Is It Linked with Declining Vaccination Rates Across Society?

    by Izabela Sztybór, Klaudia Brygida Kułak, Karolina Alicja Palacz, Marzena Pliszka, Izabela Janik, Katarzyna Gadżała, Katarzyna Chamera-Cyrek, Anna Maria Koman, Martyna Kuśmierska, Sabina Przygodzka

    Introduction. Childhood infectious diseases have been a significant medical problem, with a global increase in recent years. Modern diagnostic methods and new vaccinations are available. Poland is part of the WHO-coordinated global measles and rubella elimination program. Controversy surrounds mandatory and recommended vaccinations in Poland. There has been a concerning increase in the abandonment of vaccinating children, leading to a resurgence of infectious diseases. In 2024, the WHO reported a significant increase in measles cases in the European region, including in Poland. It's crucial to remind people of these diseases and warn them about the complications they bring. Aim of study. The aim of this study is to investigate the increasing occurrence of infectious diseases in childhood and examine the correlation with declining vaccination rates across society. Materials and methods. An unsystematic review of scientific literature was conducted, employing specific keywords such as „measles,” „pertussis,” „rubella,” „infectious diseases,” „vaccination,” and „hib.” The review was executed on the PubMed database, analyzing a total of 59 sources published until the conclusion of 2024. Conclusions. To control and eliminate infectious diseases, it is vital to maintain and improve vaccination rates. Policymakers and healthcare providers should prioritize immunization programs and address barriers to vaccine access. Further research is crucial to develop comprehensive strategies for increasing vaccination coverage and understanding vaccine-preventable diseases in modern public health challenges.


  • Open Access

    The Beneficial Effects of Aerobic Exercise on Human Systems and Organs: A Literature Review

    by Anna Maria Koman, Katarzyna Chamera-Cyrek, Marzena Pliszka, Izabela Janik, Katarzyna Gadżała, Karolina Alicja Palacz, Klaudia Brygida Kułak, Izabela Sztybór

    Introduction: Engaging in regular aerobic exercise can have a tremendous impact on one's physical and mental well-being. Despite the known benefits, a significant number of adults worldwide continue to lead sedentary lifestyles. Aerobic exercise, in particular, has been shown to improve lipid profiles, reducing the risk of cardiovascular diseases and mortality rates. Additionally, it promotes healthy metabolism, hormonal balance, and mental well-being, all of which contribute to overall health and quality of life. This is especially crucial for cancer patients undergoing treatment. Aim of the Study: The primary objective of this study is to conduct a comprehensive analysis of the physiological and psychological benefits of aerobic exercise on the human body. Description of the State of Knowledge: Moderate and regular aerobic exercise has been shown to have a beneficial effect on both physical and mental health. The importance of improving physical performance, overall body fitness, endurance, strength, balance, and mobility cannot be overstated, as it has a proven therapeutic and preventive effect against various diseases. Materials and methods: An unsystematic scientific literature review was conducted using specific keywords such as earobic exercise, lipid profile, cardiovascular system, cardiovascular disease, diabetes. The review was carried out on PubMed, analyzing a total of 70 sources published until 2023. Conclusions: Exercise has beneficial effects on all organ systems and is a non-pharmacological form of treatment for cardiovascular, musculoskeletal, metabolic and nervous system diseases. They have the benefits of reducing stress, lowering blood pressure, stimulating osteogenesis, and having a beneficial effect on body shape and self-perception. Exercise can be considered an effective treatment for established diseases or the alleviation of their symptoms.